7DK-59338-37870
2 vaccinations
2 coded responses
27 check-ins
2 free-text entries
1 call case
- Sex
- —
- Age at first dose
- 46-50
- ZIP prefix
- 115 / NY
- Registered
- 2021-04-18
- Relationship
- Self
- Race
- White
- Ethnicity
- N/A
Timeline
-
2021-04-18
Registered in v-safe
-
2021-04-18
Dose 1 — Moderna
- 2021-04-18
-
2021-04-19
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain, Itching · Chills, Joint pains, Muscle or body achesAdult check-in
- 2021-04-20
- 2021-04-21
- 2021-04-22
- 2021-04-23
- 2021-04-24
- 2021-04-25
- 2021-05-02
- 2021-05-09
- 2021-05-16
-
2021-05-18
Dose 2 — Moderna
- 2021-05-18
-
2021-05-19
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
-
2021-05-20
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Joint pains, Muscle or body achesAdult check-in
-
2021-05-21
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Headache, Muscle or body achesAdult check-in
-
2021-05-22
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Headache, Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-05-23
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Headache, Muscle or body achesAdult check-in
- 2021-05-24
- 2021-05-25
- 2021-06-01
- 2021-06-09
- 2021-06-15
- 2021-06-22
- 2021-06-29
- 2021-08-17
-
2021-11-16
Survey response — 6 months, dose 2MedDRA: Dyspnoea — Feeling: FairFree text: Slight breathing problems, especially at nightMedDRA releases: 2024-11 · check-in free text available
-
2022-05-18
Survey response — 12 months, dose 2MedDRA: Headache, Oxygen saturation decreased, Respiratory disorder, Visual impairment — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Emergency room or emergency department visitFree text: Low blood o2 breathing problems headaches vision problemsMedDRA releases: 2024-11 · check-in free text available
-
2022-05-18
Report sent to call center — 12 months, dose 2Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prEmergency room or emergency department visit · 1 call case(s)
-
2022-05-19
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-04-18 | Moderna | |
| 2 | 2021-05-18 | Moderna |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2022-05-18 | Successful 2022-05-19 |
Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill |
Free text
Release 10 — 6 months, dose 2
Symptoms: Slight breathing problems, especially at night
Release 11 — 12 months, dose 2
Symptoms: Low blood o2 breathing problems headaches vision problems
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Dyspnoea | · | · | ✓ |
| SD | Headache | · | · | ✓ |
| SD | Oxygen saturation decreased | · | · | ✓ |
| SD | Respiratory disorder | · | · | ✓ |
| SD | Visual impairment | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release